AzTrials
AzTrials

DepressionNCT07741422

Investigating a Mediation Model of Emotion Regulation and Psychological Resilience in Relationship Between Mindfulness and Negative Emotions Among College Students in Guangzhou

A study testing Mindfulness-Based Intervention and Health Education in people with Depression and Anxiety, run by Universiti Sains Malaysia at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study examines whether a four-week mindfulness-based intervention can reduce depression, anxiety, and stress among college students in Guangzhou, China. It also investigates whether changes in mindfulness, emotion regulation, and psychological resilience may help explain the effects of the intervention. Read more about this study

Who is it for?
Ages 18 to 30 years
Conditions the study is for
Depression, Anxiety, Stress
What is being tested?
Mindfulness-Based Intervention and Health Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
135 participants
Where
1 siteChina
Study dates
1 Apr 2026to 20 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • - Full-time college students enrolled at a participating institution in Guangzhou, China.
  • Aged 18 to 30 years.
  • Able to read and understand Chinese.
  • Willing to provide informed consent.
  • Completed the initial questionnaire assessment.
  • Reported at least mild symptoms of depression, anxiety, or stress on at least one subscale of the Depression Anxiety Stress Scales-21.
  • Willing and able to participate in the four-week intervention and complete the required assessm

Who cannot join

  • - Currently receiving psychiatric or psychological treatment.
  • Diagnosed with a severe mental disorder or other severe psychopathology that could interfere with participation.
  • At acute risk of suicide or self-harm.
  • Currently participating in another psychological or mental health intervention.
  • Currently engaging in regular mindfulness meditation or enrolled in another mindfulness-based program.
  • Pregnant.
  • Having a physical or medical condition that prevents participation in the intervention activities.
  • Unable to complete the intervention or study assessments.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Guangzhou City Construction College

    Guangzhou, Guangdong, 715517

Other trials in China

About this study

This study examines whether a four-week mindfulness-based intervention can reduce depression, anxiety, and stress among college students in Guangzhou, China. It also investigates whether changes in mindfulness, emotion regulation, and psychological resilience may help explain the effects of the intervention.

Eligible participants will be randomly assigned to either a mindfulness intervention group or a health education control group. The intervention group will receive weekly mindfulness-based training and complete brief daily mindfulness practice, while the control group will receive health education sessions. Participants will complete questionnaires assessing mindfulness, cognitive reappraisal, expressive suppression, psychological resilience, depression, anxiety, and stress before and after the intervention and at follow-up.

Being tested
Mindfulness-Based Intervention, Health Education
Keywords
Mindfulness, Mindfulness-Based Intervention, Emotion Regulation, Cognitive Reappraisal, Expressive Suppression, Psychological Resilience, College Students, Negative Emotions
Medical subject headings
Depression, Anxiety Disorders, Emotional Regulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness-Based InterventionBehavioural

    Participants received a four-week mindfulness-based intervention consisting of one 90-minute group session per week and approximately 10 minutes of daily home practice. The program included mindful breathing, body scan practice, mindful movement, awareness of thoughts and emotions, and exercises for responding to stress. The intervention was adapted from mindfulness-based stress reduction principles for college students.

  • Health EducationBehavioural

    Participants received a four-week health education program consisting of one group session per week. The sessions addressed general stress management, emotional well-being, healthy lifestyle practices, and other health-related topics. The program did not include mindfulness meditation or formal mindfulness practice.

Study groups in NCT07741422
Study groupRoleWhat they receive
Mindfulness-Based InterventionExperimentalParticipants in this arm will receive a four-week mindfulness-based intervention. The program includes weekly group sessions and brief daily home practice focusing on mindful breathing, body awareness, mindful movement, and awareness of thoughts and emotions.
Receives: Behavioral: Mindfulness-Based Intervention
Health Education Control GroupActive comparatorParticipants in this arm will receive health education sessions of comparable frequency and duration, focusing on stress management, emotional well-being, and healthy lifestyle practices.
Receives: Behavioral: Health Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Depression, Anxiety, and Stress Symptoms Assessed by the Depression Anxiety Stress Scales-21

    Depression, anxiety, and stress symptoms will be assessed using the 21-item Depression Anxiety Stress Scales (DASS-21). The scale contains three 7-item subscales measuring depression, anxiety, and stress. Each item is rated from 0 to 3. Subscale scores are summed and multiplied by two, with higher scores indicating greater symptom severity.

    Measured: Baseline and immediately after the 4-week intervention

Secondary outcomes (4)
  1. Change in Mindfulness Assessed by the 15-Item Five Facet Mindfulness Questionnaire

    Mindfulness will be assessed using the 15-item Five Facet Mindfulness Questionnaire (FFMQ-15). Items are rated on a Likert-type scale and summed to produce a total score, with higher scores indicating a higher level of mindfulness.

    Measured: Baseline and immediately after the 4-week intervention

  2. Change in Cognitive Reappraisal Assessed by the Emotion Regulation Questionnaire

    Cognitive reappraisal will be assessed using the 6-item cognitive reappraisal subscale of the Emotion Regulation Questionnaire. Items are rated from 1 to 7 and summed, with higher scores indicating greater use of cognitive reappraisal.

    Measured: Baseline and immediately after the 4-week intervention

  3. Change in Expressive Suppression Assessed by the Emotion Regulation Questionnaire

    Expressive suppression will be assessed using the 4-item expressive suppression subscale of the Emotion Regulation Questionnaire. Items are rated from 1 to 7 and summed, with higher scores indicating greater use of expressive suppression.

    Measured: Baseline and immediately after the 4-week intervention

  4. Change in Psychological Resilience Assessed by the Connor-Davidson Resilience Scale

    Psychological resilience will be assessed using the Connor-Davidson Resilience Scale. Item scores are summed to produce a total score, with higher scores indicating greater psychological resilience.

    Measured: Baseline and immediately after the 4-week intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2026
  2. Study start1 Apr 2026
  3. Primary completion20 Apr 2026
  4. Study completion20 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
135 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07741422
Sponsor's protocol ID
USM/JEPeM/KK/25090763
Status last verified
Jan 2026
First submitted
27 Jul 2026
Last updated
3 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared publicly because the consent obtained from participants did not specifically include public or external sharing of individual-level data. Only aggregated and de-identified study findings will be reported in publications and academic presentations.

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness-Based Intervention and Health Education in people with Depression and Anxiety, run by Universiti Sains Malaysia at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Depression, Anxiety, and Stress Symptoms Assessed by the Depression Anxiety Stress Scales-21 (time frame: Baseline and immediately after the 4-week intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in